STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
24.27
+0.30 (1.25%)
At close: Jul 21, 2026, 4:00 PM EDT
24.30
+0.03 (0.12%)
After-hours: Jul 21, 2026, 6:27 PM EDT

STAAR Surgical Company Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, STAAR Surgical Company stock has a consensus rating of "Buy" and an average price target of $29.67. The average 1-year stock price forecast is 22.25% higher than the current stock price, while the lowest is $23 (-5.23%) and the highest is $40 (+64.81%).

Price Target: $29.67 (+22.25%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$23$29.67$29$40
Change-5.23%+22.25%+19.49%+64.81%

Analyst Ratings

The average analyst rating for STAAR Surgical Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJan '26Feb '26Mar '26Apr '26May '26Jul '26
Strong Buy111233
Buy000000
Hold91010988
Sell000000
Strong Sell110000
Total111211111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$32
BuyMaintains$32+31.85%Jul 17, 2026
Piper Sandler
Piper Sandler
Hold
Maintains
$33
HoldMaintains$33+35.97%Jul 17, 2026
Needham
Needham
Hold
Maintains
n/a
HoldMaintainsn/an/aJul 17, 2026
BTIG
BTIG
Hold
Maintains
n/a
HoldMaintainsn/an/aJul 17, 2026
Wedbush
Wedbush
Buy
Reiterates
$40
BuyReiterates$40+64.81%Jul 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
338.18M
from 239.44M
Increased by 41.24%
Revenue Next Year
361.47M
from 338.18M
Increased by 6.89%
EPS This Year
0.73
from -0.17
EPS Next Year
0.99
from 0.73
Increased by 35.69%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 30, 2022Dec 29, 2023Dec 27, 2024Jan 2, 2026Dec 31, 2026
Revenue
230.47M284.39M322.42M313.90M239.44M338.18M
Revenue Growth
41.00%23.40%13.37%-2.64%-23.72%41.24%
Gross Profit
178.64M223.38M252.65M239.58M182.42M251.60M
Gross Margin
77.51%78.55%78.36%76.32%76.19%74.40%
Operating Income
33.24M44.30M29.71M-12.35M-45.74M17.90M
Net Income
27.51M39.67M21.35M-20.21M-80.45M17.12M
EPS
-----0.170.73
Forward PE
99.9741.4431.2134.6746.8333.31
Free Cash Flow
25.99M8.71M-2.79M15.79M14.61M35.20M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High354.1M
Avg338.2M
Low330.0M

Revenue Growth

Revenue Growth202620272028
High
47.9%
Avg
41.2%
Low
37.8%

EPS Forecast

EPS202620272028
High1.18
Avg0.73
Low0.39

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-